These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Emerging problems of antibiotic resistant bacteria. Smith JM N Z Med J; 1998 Nov; 111(1078):441-4. PubMed ID: 9891561 [No Abstract] [Full Text] [Related]
43. [Antibiotic resistance in respiratory tract infections: what can we do?]. Flückiger U Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707 [TBL] [Abstract][Full Text] [Related]
44. [Strategies for recognition, prevention and control of antimicrobial resistances in Germany - a draft from the Federal German Ministry of Health]. Barger A; Schaade L; Krause G; Kramer M Gesundheitswesen; 2008 Nov; 70(11):631-5. PubMed ID: 19039718 [TBL] [Abstract][Full Text] [Related]
46. Update on emerging infections:news from the Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Barrett TW; Moran GJ Ann Emerg Med; 2004 Jan; 43(1):43-5; discussion 45-7. PubMed ID: 14707939 [No Abstract] [Full Text] [Related]
47. Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. Rennie RP; Ibrahim KH Clin Infect Dis; 2005 Aug; 41 Suppl 4():S234-8. PubMed ID: 16032558 [TBL] [Abstract][Full Text] [Related]
48. Bon voyage. Hall S Nurs Times; 1999 Apr 28-May 4; 95(17):26-7. PubMed ID: 10514710 [No Abstract] [Full Text] [Related]
49. Antimicrobial resistance: insights into control and treatment of complicated infections. Introduction. Rapp RP Pharmacotherapy; 2005 Oct; 25(10 Pt 2):41S-43S. PubMed ID: 16178674 [No Abstract] [Full Text] [Related]
50. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. Chopra I; Hodgson J; Metcalf B; Poste G JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021 [No Abstract] [Full Text] [Related]
51. Gastrointestinal disease in the domestic setting: what can we deduce from surveillance data? Day C J Infect; 2001 Jul; 43(1):30-5. PubMed ID: 11597155 [No Abstract] [Full Text] [Related]
52. Any impact of bacterial resistance on antibiotic use in the community? Guillemot D; Courvalin P Int J Med Microbiol; 2002 Jun; 292(1):1-2. PubMed ID: 12139423 [No Abstract] [Full Text] [Related]
53. Control of infections. Waiyaki PG East Afr Med J; 1991 Jul; 68(7):497-9. PubMed ID: 1756700 [No Abstract] [Full Text] [Related]
54. [Emerging diseases, a challenge to the future. Conclusions]. Martino O Medicina (B Aires); 1998; 58 Suppl 1():14. PubMed ID: 9674239 [No Abstract] [Full Text] [Related]
55. Spreading the handwashing message: an alternative to traditional media campaigns. Rosen L; Brody D; Zucker D; Manor O; Meier M; Rosen B; Lev E; Engelhard D Am J Infect Control; 2010 Sep; 38(7):562-4. PubMed ID: 20381917 [TBL] [Abstract][Full Text] [Related]
56. Antimicrobial drug resistance threat: our duty towards future generations. Fukuda K East Mediterr Health J; 2013 May; 19(5):399. PubMed ID: 24617116 [No Abstract] [Full Text] [Related]
57. Preventing infection in rehabilitation centres. Mousley N Nurs Stand; 2015 May; 29(38):43-7. PubMed ID: 25990181 [TBL] [Abstract][Full Text] [Related]
58. [Model project RAI reveals significant knowledge gaps in the use of antibiotics]. Panknin HT Kinderkrankenschwester; 2015 Jul; 34(7):274. PubMed ID: 26314151 [No Abstract] [Full Text] [Related]
59. [Current communicable disease control--part 1. Uneven fight against "new and old" contagions and antibiotic resistance]. Källenius G; Andersson D Lakartidningen; 2000 Oct; 97(42):4728-32. PubMed ID: 11079323 [No Abstract] [Full Text] [Related]